Please login to the form below

Not currently logged in
Email:
Password:

NICE

This page shows the latest NICE news and features for those working in and with pharma, biotech and healthcare.

NICE recommends Sanofi and Regeneron’s Libtayo for advanced CSCC

NICE recommends Sanofi and Regeneron’s Libtayo for advanced CSCC

NICE’s decision was based on positive results from the EMPOWER-CSCC-1 trial. ... NICE first recommended that Libtayo should be made available through the Cancer Drugs Fund (CDF) in 2019.

Latest news

More from news
Approximately 417 fully matching, plus 837 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 11 fully matching, plus 133 partially matching documents found.

Latest appointments

More from appointments
Approximately 4 fully matching, plus 10 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 56 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

How ‘Greenwashing’ accusations could delay the very changes its supporters demand
Are shouts of companies ‘greenwashing’ to provide a façade of environmental and ethical respectability causing more harm than good? Or should we call out practices that we believe are papering...
What does the future hold for clinical trial recruitment?
The past couple of years have raised several aspects of healthcare in the public’s consciousness – and one of the leading ones has been the role of clinical trials in...
When is an agency not an agency?
The PR Week UK Top 150 Consultancies prompts anticipation and curiosity. But can a virtual collective of freelancers fairly be compared and ranked against conventional agencies?...